Lupin Receives U.S. FDA Approval for $52.3 Million Market Vitamin K Injectable
Lupin Ltd receives U.S. FDA approval for Phytonadione Injectable Emulsion USP, targeting a $52.3 million annual market for vitamin K deficiency treatments.
Lupin Ltd
Latest Lupin Ltd stock news from NSE and BSE filings, 3 stories so far.
